Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Monosomy 16 as the sole abnormality in myeloid malignancies.

McGhee EM, Cohen NR, Wolf JL, Ledesma CT, Cotter PD.

Cancer Genet Cytogenet. 2000 Apr 15;118(2):163-6. Review.

PMID:
10748300
2.

Deletion of 16q11 is a recurrent cytogenetic aberration in acute myeloblastic leukemia during disease progression.

Yamamoto K, Nagata K, Kida A, Hamaguchi H.

Cancer Genet Cytogenet. 2001 Nov;131(1):65-8.

PMID:
11734321
3.

AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.

Estey E, Trujillo JM, Cork A, O'Brien S, Beran M, Kantarjian H, Keating M, Freireich EJ, Stass S.

Hematol Pathol. 1992;6(1):43-8.

PMID:
1601822
4.

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study.

Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U, Fischer A, Forestier E, Fynn A, Haas OA, Harbott J, Harrison CJ, Heerema NA, van den Heuvel-Eibrink MM, Kaspers GJ, Locatelli F, Noellke P, Polychronopoulou S, Ravindranath Y, Razzouk B, Reinhardt D, Savva NN, Stark B, Suciu S, Tsukimoto I, Webb DK, Wojcik D, Woods WG, Zimmermann M, Niemeyer CM, Raimondi SC.

Blood. 2007 Jun 1;109(11):4641-7.

5.

Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16.

Xu W, Zhou HF, Fan L, Qian SX, Chen LJ, Qiu HR, Zhang SJ, Li JY.

Onkologie. 2008 Sep;31(8-9):440-4. doi: 10.1159/000141917.

PMID:
18787351
6.

Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.

Cordoba I, González-Porras JR, Nomdedeu B, Luño E, de Paz R, Such E, Tormo M, Vallespi T, Collado R, Xicoy B, Andreu R, Muñoz JA, Solé F, Cervera J, del Cañizo C; Spanish Myelodysplastic Syndrome Registry..

Cancer. 2012 Jan 1;118(1):127-33. doi: 10.1002/cncr.26279.

7.
8.

Possible evidence for genomic imprinting in childhood acute myeloblastic leukaemia associated with monosomy for chromosome 7.

Katz F, Webb D, Gibbons B, Reeves B, McMahon C, Chessells J, Mitchell C.

Br J Haematol. 1992 Mar;80(3):332-6.

PMID:
1581212
9.

Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.

Liu YC, Miyazawa K, Sashida G, Kodama A, Ohyashiki K.

Cancer Genet Cytogenet. 2006 Aug;169(1):69-72.

PMID:
16875940
10.

Monosomy X as a recurring sole cytogenetic abnormality associated with myelodysplastic diseases.

Abruzzese E, Rao PN, Slatkoff M, Cruz J, Powell BL, Jackle B, Pettenati MJ.

Cancer Genet Cytogenet. 1997 Feb;93(2):140-6. Review.

PMID:
9078298
11.

Benign chronic neutropenia with abnormalities involving 16q22, affecting mother and daughter.

Glasser L, Meloni-Ehrig A, Joseph P, Mendiola J.

Am J Hematol. 2006 Apr;81(4):262-70.

12.

Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.

de Souza Fernandez T, Ornellas MH, Otero de Carvalho L, Tabak D, Abdelhay E.

Leuk Res. 2000 Oct;24(10):839-48.

PMID:
10996202
13.

Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).

Ogasawara T, Yasuyama M, Kawauchi K.

Am J Hematol. 2005 Jun;79(2):136-41. Review.

14.

Lymphoid blastic crisis of chronic myelogenous leukaemia with inv(16)(p13;q22).

Tsuboi K, Komatsu H, Miwa H, Iida S, Banno S, Wakita A, Nitta M, Ueda R.

Leuk Res. 2002 Aug;26(8):771-4.

PMID:
12191573
15.

Monosomy 7 predisposes to diabetes insipidus in leukaemia and myelodysplastic syndrome.

de la Chapelle A, Lahtinen R.

Eur J Haematol. 1987 Nov;39(5):404-11. Review.

PMID:
3319680
16.

[Chromosome 17 abnormalities in patients with primary myelodysplastic syndrome: incidence and biologic significance].

Marisavljević D, Rolović Z, Panitić M, Novak A, Djordjević V, Lazarević V, Bosković D, Colović M.

Srp Arh Celok Lek. 2004 Jan-Feb;132(1-2):10-3. Serbian.

17.

Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia.

Bram S, Swolin B, Rödjer S, Stockelberg D, Ogärd I, Bäck H.

Cancer Genet Cytogenet. 2003 Apr 15;142(2):107-14.

PMID:
12699885
18.

Immunohistochemical analysis of CBFbeta-SMMHC protein reveals a unique nuclear localization in acute myeloid leukemia with inv(16)(p13q22).

Zhao W, Claxton DF, Medeiros LJ, Lu D, Vadhan-Raj S, Kantarjian HM, Nguyen MH, Bueso-Ramos CE.

Am J Surg Pathol. 2006 Nov;30(11):1436-44.

PMID:
17063086
19.

A new reliable fluorescence in situ hybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia.

Valencia A, Cervera J, Such E, Ibañez M, Barragán E, Fuster O, Bolufer P, Moscardó F, Sanz MA.

Leuk Lymphoma. 2010 Apr;51(4):680-5. doi: 10.3109/10428191003682775.

PMID:
20233056
20.

Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML.

Herry A, Douet-Guilbert N, Morel F, Le Bris MJ, De Braekeleer M.

Eur J Haematol. 2007 Jun;78(6):457-67.

PMID:
17391336
Items per page

Supplemental Content

Support Center